PA8632101A1 - Derivados de benceno halogenados sustituidos con trímeros macrocíclicos - Google Patents

Derivados de benceno halogenados sustituidos con trímeros macrocíclicos

Info

Publication number
PA8632101A1
PA8632101A1 PA20058632101A PA8632101A PA8632101A1 PA 8632101 A1 PA8632101 A1 PA 8632101A1 PA 20058632101 A PA20058632101 A PA 20058632101A PA 8632101 A PA8632101 A PA 8632101A PA 8632101 A1 PA8632101 A1 PA 8632101A1
Authority
PA
Panama
Prior art keywords
benchen
trimmers
macrocyclic
halogenated
derivatives replaced
Prior art date
Application number
PA20058632101A
Other languages
English (en)
Inventor
Juan R Harto
Jose L Martin
Johannes Platzek
Heiko Schirmer
Hanns-Joachim Weinmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PA8632101A1 publication Critical patent/PA8632101A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

COMPLEJO METALICOS DE LA FORMULA I DONDE HAL ES BROMO O YODO Y A1 Y A2 TIENEN SIGNIFICADO DOFERENTE, QUE SON APROPIADOS COMO MEDIOS DE CONTRASTE.
PA20058632101A 2004-05-05 2005-05-05 Derivados de benceno halogenados sustituidos con trímeros macrocíclicos PA8632101A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004023093A DE102004023093B3 (de) 2004-05-05 2004-05-05 Trimere makrocyclisch substituierte Halogen-Benzolderivate

Publications (1)

Publication Number Publication Date
PA8632101A1 true PA8632101A1 (es) 2006-07-03

Family

ID=34967980

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20058632101A PA8632101A1 (es) 2004-05-05 2005-05-05 Derivados de benceno halogenados sustituidos con trímeros macrocíclicos

Country Status (18)

Country Link
US (1) US7385054B2 (es)
EP (1) EP1742926B1 (es)
JP (1) JP2007536295A (es)
AR (1) AR050984A1 (es)
AT (1) ATE369347T1 (es)
DE (2) DE102004023093B3 (es)
DK (1) DK1742926T3 (es)
ES (1) ES2289711T3 (es)
GT (1) GT200500106A (es)
PA (1) PA8632101A1 (es)
PE (1) PE20060350A1 (es)
PL (1) PL1742926T3 (es)
PT (1) PT1742926E (es)
SI (1) SI1742926T1 (es)
SV (1) SV2006002104A (es)
TW (1) TW200539894A (es)
UY (1) UY28884A1 (es)
WO (1) WO2005108379A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
KR101209633B1 (ko) * 2009-09-09 2012-12-06 주식회사 휴메딕스 페길레이션된 삼요오드화 아릴 화합물 및 그를 포함하는 ｘ-선 조영제
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
CA3120665A1 (en) 2018-11-23 2020-05-28 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
WO1994027644A1 (en) * 1993-06-02 1994-12-08 Bracco S.P.A. Iodinated paramagnetic chelates, and their use as contrast agents
DE10307759B3 (de) * 2003-02-19 2004-11-18 Schering Ag Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel
US7208140B2 (en) * 2003-02-19 2007-04-24 Schering Aktiengesellschaft Trimeric macrocyclic substituted benzene derivatives

Also Published As

Publication number Publication date
ATE369347T1 (de) 2007-08-15
TW200539894A (en) 2005-12-16
WO2005108379A1 (de) 2005-11-17
EP1742926A1 (de) 2007-01-17
DK1742926T3 (da) 2007-10-15
GT200500106A (es) 2005-12-15
JP2007536295A (ja) 2007-12-13
PE20060350A1 (es) 2006-05-25
SV2006002104A (es) 2006-02-15
PL1742926T3 (pl) 2007-12-31
ES2289711T3 (es) 2008-02-01
UY28884A1 (es) 2005-11-30
AR050984A1 (es) 2006-12-13
PT1742926E (pt) 2007-09-24
US20060154989A1 (en) 2006-07-13
SI1742926T1 (sl) 2007-12-31
EP1742926B1 (de) 2007-08-08
US7385054B2 (en) 2008-06-10
DE102004023093B3 (de) 2006-03-02
DE502005001194D1 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
BRPI0718266A2 (pt) Compostos heterocíclicos como agentes anti-inflamatórios.
HN2007015177A (es) Derivados de triazolopirazina
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
ATE525353T1 (de) Trifluormethoxy-phenylsubstituierte tetramsäure- derivate als schädlingsbekämpfungsmittel und/oder herbizide
BRPI0720355B8 (pt) Composições oftálmicas para o tratamento de presbiopia, bem como o uso das mesmas
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
BRPI0923747A2 (pt) "tratamento de safras transgênicas com misturas de fiprolas e cloroniconilas".
BRPI0919295A2 (pt) 1h-benzimidazol-5-carboxamidas como agentes anti-inflamatórios.
ATE530210T1 (de) Endoprothesen
EA200802428A1 (ru) Комбинации агентов для биологической борьбы и нематоцидов, входящих в покрытие семян
DE602006010508D1 (de) Substituierte triazolderivate als oxytocinantagonisten
DK1863899T3 (da) Hudbehandlingspræparater
ECSP056026A (es) Derivados de benceno sustituidos con trímeros macrocíclicos
BRPI1008899A2 (pt) derivados 3,3´-espiroindolinona como agentes anticâncer
NL1032915A1 (nl) Katheterpunt.
BRPI1010254A2 (pt) "derivados de pirrolidina diona espiroheterocíclica utilizada como pesticida."
BRPI0605926A2 (pt) ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos
EA201000258A1 (ru) Новые гербициды
PA8632101A1 (es) Derivados de benceno halogenados sustituidos con trímeros macrocíclicos
CR20110660A (es) Mezclas fungicidas
BRPI1008175A2 (pt) "corpo de veículo, mais particularmente corpo de veículo terrestre"
CR10637A (es) Fungicidas
PT1556377E (pt) Ciclopropil-tienil-carboxamidas como fungicidas
ATE507245T1 (de) Bekämpfung von schädlichen nagetieren
PA8619601A1 (es) Derivados oxazol de tetraciclinas